<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1999-07-15" modified="2020-08-12" version="191">
<accession>O95180</accession>
<accession>B5ME00</accession>
<accession>F8WFD1</accession>
<accession>O95802</accession>
<accession>Q8WWI6</accession>
<accession>Q96QI6</accession>
<accession>Q96RZ9</accession>
<accession>Q9NYY4</accession>
<accession>Q9NYY5</accession>
<name>CAC1H_HUMAN</name>
<protein>
<recommendedName>
<fullName>Voltage-dependent T-type calcium channel subunit alpha-1H</fullName>
</recommendedName>
<alternativeName>
<fullName>Low-voltage-activated calcium channel alpha1 3.2 subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Voltage-gated calcium channel subunit alpha Cav3.2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="21">CACNA1H</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Circ. Res." volume="83" first="103" last="109">
<title>Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.</title>
<authorList>
<person name="Cribbs L.L."/>
<person name="Lee J.-H."/>
<person name="Yang J."/>
<person name="Satin J."/>
<person name="Zhang Y."/>
<person name="Daud A.N."/>
<person name="Barclay J."/>
<person name="Wiliamson M.P."/>
<person name="Fox M."/>
<person name="Rees M."/>
<person name="Perez-Reyes E."/>
</authorList>
<dbReference type="PubMed" id="9670923"/>
<dbReference type="DOI" id="10.1161/01.res.83.1.103"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-664</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2001-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Cribbs L.L."/>
<person name="Lee J.-H."/>
<person name="Yang J."/>
<person name="Daud A.N."/>
<person name="Perez-Reyes E."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="J. Neurochem." volume="72" first="791" last="799">
<title>Structure and functional characterization of a novel human low-voltage activated calcium channel.</title>
<authorList>
<person name="Williams M.E."/>
<person name="Washburn M.S."/>
<person name="Hans M."/>
<person name="Urrutia A."/>
<person name="Brust P.F."/>
<person name="Prodanovich P."/>
<person name="Harpold M.M."/>
<person name="Stauderman K.A."/>
</authorList>
<dbReference type="PubMed" id="9930755"/>
<dbReference type="DOI" id="10.1046/j.1471-4159.1999.0720791.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>VARIANT HIS-2077</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Thyroid carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8449" last="8456">
<title>Identification and localization of T-type voltage-operated calcium channel subunits in human male germ cells. Expression of multiple isoforms.</title>
<authorList>
<person name="Jagannathan S."/>
<person name="Punt E.L."/>
<person name="Gu Y."/>
<person name="Arnoult C."/>
<person name="Sakkas D."/>
<person name="Barratt C.L."/>
<person name="Publicover S.J."/>
</authorList>
<dbReference type="PubMed" id="11751928"/>
<dbReference type="DOI" id="10.1074/jbc.m105345200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT ALA-664</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="339" last="352">
<title>Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.</title>
<authorList>
<person name="Daniels R.J."/>
<person name="Peden J.F."/>
<person name="Lloyd C."/>
<person name="Horsley S.W."/>
<person name="Clark K."/>
<person name="Tufarelli C."/>
<person name="Kearney L."/>
<person name="Buckle V.J."/>
<person name="Doggett N.A."/>
<person name="Flint J."/>
<person name="Higgs D.R."/>
</authorList>
<dbReference type="PubMed" id="11157797"/>
<dbReference type="DOI" id="10.1093/hmg/10.4.339"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS VAL-313 AND HIS-2060</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT VAL-313</scope>
</reference>
<reference key="7">
<citation type="submission" date="2001-01" db="EMBL/GenBank/DDBJ databases">
<title>Organization and alternative splicing of CACNA1H.</title>
<authorList>
<person name="Mittman S."/>
<person name="Agnew W.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 424-661 AND 838-2373 (ISOFORM 1)</scope>
<scope>VARIANTS LEU-640 AND HIS-2077</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3271" last="3281">
<title>Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels.</title>
<authorList>
<person name="Kang H.W."/>
<person name="Vitko I."/>
<person name="Lee S.S."/>
<person name="Perez-Reyes E."/>
<person name="Lee J.H."/>
</authorList>
<dbReference type="PubMed" id="19940152"/>
<dbReference type="DOI" id="10.1074/jbc.m109.067660"/>
</citation>
<scope>ZINC-BINDING SITES</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2016" name="Channels" volume="10" first="346" last="354">
<title>A Cav3.2/Stac1 molecular complex controls T-type channel expression at the plasma membrane.</title>
<authorList>
<person name="Rzhepetskyy Y."/>
<person name="Lazniewska J."/>
<person name="Proft J."/>
<person name="Campiglio M."/>
<person name="Flucher B.E."/>
<person name="Weiss N."/>
</authorList>
<dbReference type="PubMed" id="27149520"/>
<dbReference type="DOI" id="10.1080/19336950.2016.1186318"/>
</citation>
<scope>INTERACTION WITH STAC</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Ann. Neurol." volume="54" first="239" last="243">
<title>Association between genetic variation of CACNA1H and childhood absence epilepsy.</title>
<authorList>
<person name="Chen Y."/>
<person name="Lu J."/>
<person name="Pan H."/>
<person name="Zhang Y."/>
<person name="Wu H."/>
<person name="Xu K."/>
<person name="Liu X."/>
<person name="Jiang Y."/>
<person name="Bao X."/>
<person name="Yao Z."/>
<person name="Ding K."/>
<person name="Lo W.H."/>
<person name="Qiang B."/>
<person name="Chan P."/>
<person name="Shen Y."/>
<person name="Wu X."/>
</authorList>
<dbReference type="PubMed" id="12891677"/>
<dbReference type="DOI" id="10.1002/ana.10607"/>
</citation>
<scope>VARIANTS ECA6 LEU-161; LYS-282; SER-456; SER-499; LEU-648; GLN-744; VAL-748; ASP-773; SER-784; MET-831; SER-848 AND ASN-1463</scope>
<scope>VARIANTS VAL-313; LEU-640; ALA-664; SER-684; CYS-788; HIS-2060; HIS-2077 AND SER-2173</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Ann. Neurol." volume="55" first="595" last="596">
<title>Genetic variation of CACNA1H in idiopathic generalized epilepsy.</title>
<authorList>
<person name="Heron S.E."/>
<person name="Phillips H.A."/>
<person name="Mulley J.C."/>
<person name="Mazarib A."/>
<person name="Neufeld M.Y."/>
<person name="Berkovic S.F."/>
<person name="Scheffer I.E."/>
</authorList>
<dbReference type="PubMed" id="15048902"/>
<dbReference type="DOI" id="10.1002/ana.20028"/>
</citation>
<scope>VARIANTS EIG6 LEU-618 AND ASP-755</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="J. Physiol. (Lond.)" volume="592" first="795" last="809">
<title>Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.</title>
<authorList>
<person name="Eckle V.S."/>
<person name="Shcheglovitov A."/>
<person name="Vitko I."/>
<person name="Dey D."/>
<person name="Yap C.C."/>
<person name="Winckler B."/>
<person name="Perez-Reyes E."/>
</authorList>
<dbReference type="PubMed" id="24277868"/>
<dbReference type="DOI" id="10.1113/jphysiol.2013.264176"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT ECA6 SER-456</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Elife" volume="4" first="E06315" last="E06315">
<title>Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.</title>
<authorList>
<person name="Scholl U.I."/>
<person name="Stoelting G."/>
<person name="Nelson-Williams C."/>
<person name="Vichot A.A."/>
<person name="Choi M."/>
<person name="Loring E."/>
<person name="Prasad M.L."/>
<person name="Goh G."/>
<person name="Carling T."/>
<person name="Juhlin C.C."/>
<person name="Quack I."/>
<person name="Rump L.C."/>
<person name="Thiel A."/>
<person name="Lande M."/>
<person name="Frazier B.G."/>
<person name="Rasoulpour M."/>
<person name="Bowlin D.L."/>
<person name="Sethna C.B."/>
<person name="Trachtman H."/>
<person name="Fahlke C."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="25907736"/>
<dbReference type="DOI" id="10.7554/elife.06315"/>
</citation>
<scope>VARIANT HALD4 VAL-1549</scope>
<scope>CHARACTERIZATION OF VARIANT HALD4 VAL-1549</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2015" name="Neuron" volume="88" first="910" last="917">
<title>Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.</title>
<authorList>
<person name="D'Gama A.M."/>
<person name="Pochareddy S."/>
<person name="Li M."/>
<person name="Jamuar S.S."/>
<person name="Reiff R.E."/>
<person name="Lam A.T."/>
<person name="Sestan N."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="26637798"/>
<dbReference type="DOI" id="10.1016/j.neuron.2015.11.009"/>
</citation>
<scope>VARIANT CYS-1970</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="EBioMedicine" volume="13" first="225" last="236">
<title>CACNA1H mutations are associated with different forms of primary aldosteronism.</title>
<authorList>
<person name="Daniil G."/>
<person name="Fernandes-Rosa F.L."/>
<person name="Chemin J."/>
<person name="Blesneac I."/>
<person name="Beltrand J."/>
<person name="Polak M."/>
<person name="Jeunemaitre X."/>
<person name="Boulkroun S."/>
<person name="Amar L."/>
<person name="Strom T.M."/>
<person name="Lory P."/>
<person name="Zennaro M.C."/>
</authorList>
<dbReference type="PubMed" id="27729216"/>
<dbReference type="DOI" id="10.1016/j.ebiom.2016.10.002"/>
</citation>
<scope>VARIANTS HALD4 LEU-196; ILE-1549 AND LEU-2083</scope>
<scope>VARIANT GLU-1951</scope>
<scope>CHARACTERIZATION OF VARIANTS HALD4 LEU-196; ILE-1549 AND LEU-2083</scope>
<scope>CHARACTERIZATION OF VARIANT GLU-1951</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="216" last="225">
<title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.</title>
<authorList>
<consortium name="Clinical Study Group"/>
<person name="Parrini E."/>
<person name="Marini C."/>
<person name="Mei D."/>
<person name="Galuppi A."/>
<person name="Cellini E."/>
<person name="Pucatti D."/>
<person name="Chiti L."/>
<person name="Rutigliano D."/>
<person name="Bianchini C."/>
<person name="Virdo S."/>
<person name="De Vita D."/>
<person name="Bigoni S."/>
<person name="Barba C."/>
<person name="Mari F."/>
<person name="Montomoli M."/>
<person name="Pisano T."/>
<person name="Rosati A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="27864847"/>
<dbReference type="DOI" id="10.1002/humu.23149"/>
</citation>
<scope>VARIANT TYR-516</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2018" name="Cell" volume="175" first="239" last="253">
<title>Mutations in disordered regions can cause disease by creating dileucine motifs.</title>
<authorList>
<person name="Meyer K."/>
<person name="Kirchner M."/>
<person name="Uyar B."/>
<person name="Cheng J.Y."/>
<person name="Russo G."/>
<person name="Hernandez-Miranda L.R."/>
<person name="Szymborska A."/>
<person name="Zauber H."/>
<person name="Rudolph I.M."/>
<person name="Willnow T.E."/>
<person name="Akalin A."/>
<person name="Haucke V."/>
<person name="Gerhardt H."/>
<person name="Birchmeier C."/>
<person name="Kuehn R."/>
<person name="Krauss M."/>
<person name="Diecke S."/>
<person name="Pascual J.M."/>
<person name="Selbach M."/>
</authorList>
<dbReference type="PubMed" id="30197081"/>
<dbReference type="DOI" id="10.1016/j.cell.2018.08.019"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT ECA6 LEU-648</scope>
</reference>
<comment type="function">
<text evidence="8 9 11 12 15 16 19 20">Voltage-sensitive calcium channel that gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group. A particularity of this type of channel is an opening at quite negative potentials, and a voltage-dependent inactivation (PubMed:9670923, PubMed:9930755, PubMed:27149520). T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle (Probable). They may also be involved in the modulation of firing patterns of neurons (PubMed:15048902). In the adrenal zona glomerulosa, participates in the signaling pathway leading to aldosterone production in response to either AGT/angiotensin II, or hyperkalemia (PubMed:25907736, PubMed:27729216).</text>
</comment>
<comment type="activity regulation">
<text evidence="15 16">Channel activity is strongly inhibited by mibefradil (PubMed:9670923, PubMed:9930755). Channel activity is strongly inhibited by Ni(2+) ions (PubMed:9930755).</text>
</comment>
<comment type="subunit">
<text evidence="11">Interacts (via N-terminal cytoplasmic domain) with STAC.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9 11 12 15 16">Cell membrane</location>
<topology evidence="19">Multi-pass membrane protein</topology>
</subcellularLocation>
<text evidence="11">Interaction with STAC increases expression at the cell membrane.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O95180-1</id>
<name>1</name>
<name>A1H-a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O95180-2</id>
<name>2</name>
<name>A1H-b</name>
<sequence type="described" ref="VSP_000949"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4 9 12 15 16">In nonneuronal tissues, the highest expression levels are found in the kidney, liver, and heart. In the brain, most abundant in the amygdala, caudate nucleus, and putamen (PubMed:9670923, PubMed:9930755). In the heart, expressed in blood vessels. Isoform 1 and isoform 2 are expressed in testis, primarily in the germ cells, but not in other portions of the reproductive tract, such as ductus deferens. Isoform 2 is not detected in brain (PubMed:11751928). Expressed in the adrenal glomerulosa (at protein level) (PubMed:25907736, PubMed:27729216).</text>
</comment>
<comment type="domain">
<text>Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position.</text>
</comment>
<comment type="PTM">
<text>In response to raising of intracellular calcium, the T-type channels are activated by CaM-kinase II.</text>
</comment>
<comment type="disease" evidence="6">
<disease id="DI-00594">
<name>Epilepsy, idiopathic generalized 6</name>
<acronym>EIG6</acronym>
<description>A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain.</description>
<dbReference type="MIM" id="611942"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="5 8 14">
<disease id="DI-03307">
<name>Epilepsy, childhood absence 6</name>
<acronym>ECA6</acronym>
<description>A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood.</description>
<dbReference type="MIM" id="611942"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="9 12">
<disease id="DI-04759">
<name>Hyperaldosteronism, familial, 4</name>
<acronym>HALD4</acronym>
<description>A form of familial hyperaldosteronism, a disorder characterized by hypertension, elevated aldosterone levels despite low plasma renin activity, and abnormal adrenal steroid production. There is significant phenotypic heterogeneity, and some individuals never develop hypertension.</description>
<dbReference type="MIM" id="617027"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="19">Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. CACNA1H subfamily.</text>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAK61268" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="CAC42094" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AF051946">
<property type="protein sequence ID" value="AAC67239.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF073931">
<property type="protein sequence ID" value="AAD17668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ420779">
<property type="protein sequence ID" value="CAD12646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AE006466">
<property type="protein sequence ID" value="AAK61268.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL031703">
<property type="protein sequence ID" value="CAC42094.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC120498">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF223562">
<property type="protein sequence ID" value="AAF60162.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF223563">
<property type="protein sequence ID" value="AAF60163.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45375.1">
<molecule id="O95180-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45376.1">
<molecule id="O95180-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005407.1">
<molecule id="O95180-2"/>
<property type="nucleotide sequence ID" value="NM_001005407.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_066921.2">
<molecule id="O95180-1"/>
<property type="nucleotide sequence ID" value="NM_021098.2"/>
</dbReference>
<dbReference type="BioGRID" id="114426">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="IntAct" id="O95180">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="MINT" id="O95180"/>
<dbReference type="STRING" id="9606.ENSP00000334198"/>
<dbReference type="BindingDB" id="O95180"/>
<dbReference type="ChEMBL" id="CHEMBL1859"/>
<dbReference type="DrugBank" id="DB09231">
<property type="generic name" value="Benidipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01244">
<property type="generic name" value="Bepridil"/>
</dbReference>
<dbReference type="DrugBank" id="DB13746">
<property type="generic name" value="Bioallethrin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11148">
<property type="generic name" value="Butamben"/>
</dbReference>
<dbReference type="DrugBank" id="DB11093">
<property type="generic name" value="Calcium citrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11348">
<property type="generic name" value="Calcium Phosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14481">
<property type="generic name" value="Calcium phosphate dihydrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09061">
<property type="generic name" value="Cannabidiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00568">
<property type="generic name" value="Cinnarizine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00153">
<property type="generic name" value="Ergocalciferol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01023">
<property type="generic name" value="Felodipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04841">
<property type="generic name" value="Flunarizine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00270">
<property type="generic name" value="Isradipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09238">
<property type="generic name" value="Manidipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB14009">
<property type="generic name" value="Medical Cannabis"/>
</dbReference>
<dbReference type="DrugBank" id="DB01388">
<property type="generic name" value="Mibefradil"/>
</dbReference>
<dbReference type="DrugBank" id="DB14011">
<property type="generic name" value="Nabiximols"/>
</dbReference>
<dbReference type="DrugBank" id="DB01115">
<property type="generic name" value="Nifedipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01054">
<property type="generic name" value="Nitrendipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09089">
<property type="generic name" value="Trimebutine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00661">
<property type="generic name" value="Verapamil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00909">
<property type="generic name" value="Zonisamide"/>
</dbReference>
<dbReference type="DrugCentral" id="O95180"/>
<dbReference type="GuidetoPHARMACOLOGY" id="536"/>
<dbReference type="TCDB" id="1.A.1.11.5">
<property type="family name" value="the voltage-gated ion channel (vic) superfamily"/>
</dbReference>
<dbReference type="GlyGen" id="O95180">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="O95180"/>
<dbReference type="PhosphoSitePlus" id="O95180"/>
<dbReference type="BioMuta" id="CACNA1H"/>
<dbReference type="jPOST" id="O95180"/>
<dbReference type="MassIVE" id="O95180"/>
<dbReference type="PaxDb" id="O95180"/>
<dbReference type="PeptideAtlas" id="O95180"/>
<dbReference type="PRIDE" id="O95180"/>
<dbReference type="ProteomicsDB" id="50690">
<molecule id="O95180-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="50691">
<molecule id="O95180-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="22964">
<property type="antibodies" value="285 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000348261">
<molecule id="O95180-1"/>
<property type="protein sequence ID" value="ENSP00000334198"/>
<property type="gene ID" value="ENSG00000196557"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000358590">
<molecule id="O95180-2"/>
<property type="protein sequence ID" value="ENSP00000351401"/>
<property type="gene ID" value="ENSG00000196557"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000565831">
<molecule id="O95180-2"/>
<property type="protein sequence ID" value="ENSP00000455840"/>
<property type="gene ID" value="ENSG00000196557"/>
</dbReference>
<dbReference type="GeneID" id="8912"/>
<dbReference type="KEGG" id="hsa:8912"/>
<dbReference type="UCSC" id="uc002cks.4">
<molecule id="O95180-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8912"/>
<dbReference type="DisGeNET" id="8912"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000196557.10"/>
<dbReference type="GeneCards" id="CACNA1H"/>
<dbReference type="HGNC" id="HGNC:1395">
<property type="gene designation" value="CACNA1H"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000196557">
<property type="expression patterns" value="Tissue enhanced (smooth)"/>
</dbReference>
<dbReference type="MalaCards" id="CACNA1H"/>
<dbReference type="MIM" id="607904">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="611942">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617027">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95180"/>
<dbReference type="OpenTargets" id="ENSG00000196557"/>
<dbReference type="Orphanet" id="64280">
<property type="disease" value="Childhood absence epilepsy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA380"/>
<dbReference type="eggNOG" id="KOG2302">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156666"/>
<dbReference type="HOGENOM" id="CLU_000540_2_0_1"/>
<dbReference type="InParanoid" id="O95180"/>
<dbReference type="KO" id="K04855"/>
<dbReference type="OMA" id="RPIHNLL"/>
<dbReference type="OrthoDB" id="172471at2759"/>
<dbReference type="PhylomeDB" id="O95180"/>
<dbReference type="TreeFam" id="TF313555"/>
<dbReference type="PathwayCommons" id="O95180"/>
<dbReference type="Reactome" id="R-HSA-419037">
<property type="pathway name" value="NCAM1 interactions"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="8912">
<property type="hits" value="6 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CACNA1H">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CACNA1H"/>
<dbReference type="GenomeRNAi" id="8912"/>
<dbReference type="Pharos" id="O95180">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:O95180"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="O95180">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196557">
<property type="expression patterns" value="Expressed in lower esophagus muscularis layer and 119 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O95180">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O95180">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005891">
<property type="term" value="C:voltage-gated calcium channel complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001518">
<property type="term" value="C:voltage-gated sodium channel complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005261">
<property type="term" value="F:cation channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008332">
<property type="term" value="F:low voltage-gated calcium channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005244">
<property type="term" value="F:voltage-gated ion channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005248">
<property type="term" value="F:voltage-gated sodium channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032342">
<property type="term" value="P:aldosterone biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070509">
<property type="term" value="P:calcium ion import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032870">
<property type="term" value="P:cellular response to hormone stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035865">
<property type="term" value="P:cellular response to potassium ion"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034651">
<property type="term" value="P:cortisol biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098662">
<property type="term" value="P:inorganic cation transmembrane transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0086010">
<property type="term" value="P:membrane depolarization during action potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006936">
<property type="term" value="P:muscle contraction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007520">
<property type="term" value="P:myoblast fusion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019228">
<property type="term" value="P:neuronal action potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000344">
<property type="term" value="P:positive regulation of acrosome reaction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045956">
<property type="term" value="P:positive regulation of calcium ion-dependent exocytosis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008016">
<property type="term" value="P:regulation of heart contraction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0034765">
<property type="term" value="P:regulation of ion transmembrane transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042391">
<property type="term" value="P:regulation of membrane potential"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.120.350">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR005821">
<property type="entry name" value="Ion_trans_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR005445">
<property type="entry name" value="VDCC_T_a1"/>
</dbReference>
<dbReference type="InterPro" id="IPR043203">
<property type="entry name" value="VGCC_Ca_Na"/>
</dbReference>
<dbReference type="InterPro" id="IPR027359">
<property type="entry name" value="Volt_channel_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10037">
<property type="entry name" value="PTHR10037"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00520">
<property type="entry name" value="Ion_trans"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PRINTS" id="PR01629">
<property type="entry name" value="TVDCCALPHA1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0107">Calcium channel</keyword>
<keyword id="KW-0109">Calcium transport</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0851">Voltage-gated channel</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Voltage-dependent T-type calcium channel subunit alpha-1H" id="PRO_0000053954">
<location>
<begin position="1"/>
<end position="2353"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1"/>
<end position="100"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S1 of repeat I" evidence="2">
<location>
<begin position="101"/>
<end position="119"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="120"/>
<end position="141"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S2 of repeat I" evidence="2">
<location>
<begin position="142"/>
<end position="160"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="161"/>
<end position="169"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S3 of repeat I" evidence="2">
<location>
<begin position="170"/>
<end position="184"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="185"/>
<end position="193"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S4 of repeat I" evidence="2">
<location>
<begin position="194"/>
<end position="212"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="213"/>
<end position="232"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S5 of repeat I" evidence="2">
<location>
<begin position="233"/>
<end position="253"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="254"/>
<end position="394"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S6 of repeat I" evidence="2">
<location>
<begin position="395"/>
<end position="419"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="420"/>
<end position="793"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S1 of repeat II" evidence="2">
<location>
<begin position="794"/>
<end position="814"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="815"/>
<end position="827"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S2 of repeat II" evidence="2">
<location>
<begin position="828"/>
<end position="849"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="850"/>
<end position="855"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S3 of repeat II" evidence="2">
<location>
<begin position="856"/>
<end position="874"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="875"/>
<end position="882"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S4 of repeat II" evidence="2">
<location>
<begin position="883"/>
<end position="906"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="907"/>
<end position="917"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S5 of repeat II" evidence="2">
<location>
<begin position="918"/>
<end position="938"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="939"/>
<end position="990"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S6 of repeat II" evidence="2">
<location>
<begin position="991"/>
<end position="1015"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1016"/>
<end position="1290"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S1 of repeat III" evidence="2">
<location>
<begin position="1291"/>
<end position="1313"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1314"/>
<end position="1331"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S2 of repeat III" evidence="2">
<location>
<begin position="1332"/>
<end position="1352"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1353"/>
<end position="1362"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S3 of repeat III" evidence="2">
<location>
<begin position="1363"/>
<end position="1382"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1383"/>
<end position="1396"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S4 of repeat III" evidence="2">
<location>
<begin position="1397"/>
<end position="1418"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1419"/>
<end position="1428"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S5 of repeat III" evidence="2">
<location>
<begin position="1429"/>
<end position="1452"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1453"/>
<end position="1529"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S6 of repeat III" evidence="2">
<location>
<begin position="1530"/>
<end position="1555"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1556"/>
<end position="1616"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S1 of repeat IV" evidence="2">
<location>
<begin position="1617"/>
<end position="1637"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1638"/>
<end position="1651"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S2 of repeat IV" evidence="2">
<location>
<begin position="1652"/>
<end position="1673"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1674"/>
<end position="1680"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S3 of repeat IV" evidence="2">
<location>
<begin position="1681"/>
<end position="1699"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1700"/>
<end position="1713"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S4 of repeat IV" evidence="2">
<location>
<begin position="1714"/>
<end position="1737"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1738"/>
<end position="1751"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S5 of repeat IV" evidence="2">
<location>
<begin position="1752"/>
<end position="1772"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1773"/>
<end position="1835"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=S6 of repeat IV" evidence="2">
<location>
<begin position="1836"/>
<end position="1863"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1864"/>
<end position="2353"/>
</location>
</feature>
<feature type="repeat" description="I">
<location>
<begin position="87"/>
<end position="422"/>
</location>
</feature>
<feature type="repeat" description="II">
<location>
<begin position="779"/>
<end position="1018"/>
</location>
</feature>
<feature type="repeat" description="III">
<location>
<begin position="1281"/>
<end position="1558"/>
</location>
</feature>
<feature type="repeat" description="IV">
<location>
<begin position="1602"/>
<end position="1863"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="520"/>
<end position="530"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="1107"/>
<end position="1110"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="1583"/>
<end position="1586"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="140"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="189"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="191"/>
</location>
</feature>
<feature type="site" description="Calcium ion selectivity and permeability" evidence="1">
<location>
<position position="378"/>
</location>
</feature>
<feature type="site" description="Calcium ion selectivity and permeability" evidence="1">
<location>
<position position="974"/>
</location>
</feature>
<feature type="site" description="Calcium ion selectivity and permeability" evidence="1">
<location>
<position position="1504"/>
</location>
</feature>
<feature type="site" description="Calcium ion selectivity and permeability" evidence="1">
<location>
<position position="1808"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="192"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="271"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="1466"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_000949" evidence="18">
<original>STFPSPE</original>
<variation>K</variation>
<location>
<begin position="1587"/>
<end position="1593"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs119454947." id="VAR_045935" evidence="5">
<original>F</original>
<variation>L</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In HALD4; changed calcium channel activity; increased aldosterone production in response to potassium ion stimulation; increased expression of genes involved in aldosterone biosynthesis, with the strongest effect observed on CYP11B2 expression in response to potassium ion stimulation; dbSNP:rs780596901." id="VAR_077064" evidence="12">
<original>S</original>
<variation>L</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs119454948." id="VAR_045936" evidence="5">
<original>E</original>
<variation>K</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs36117280." id="VAR_045937" evidence="3 5 7">
<original>M</original>
<variation>V</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; results in increased T-current amplitude and lower threshold for spikes generation; results in increased neuronal excitability." id="VAR_045938" evidence="5 8">
<original>C</original>
<variation>S</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs560915333." id="VAR_045939" evidence="5">
<original>G</original>
<variation>S</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with drug-resistant focal epilepsy; unknown pathological significance; dbSNP:rs1057519554." id="VAR_078237" evidence="13">
<original>H</original>
<variation>Y</variation>
<location>
<position position="516"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG6; dbSNP:rs60734921." id="VAR_066986" evidence="6">
<original>P</original>
<variation>L</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61734410." id="VAR_045940" evidence="5 17">
<original>P</original>
<variation>L</variation>
<location>
<position position="640"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; creates a dileucine internalization motif that promotes recruitment of clathrin; dbSNP:rs1288484976." id="VAR_045941" evidence="5 14">
<original>P</original>
<variation>L</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4984636." id="VAR_045942" evidence="4 5 15">
<original>V</original>
<variation>A</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs762185083." id="VAR_045943" evidence="5">
<original>P</original>
<variation>S</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs373764821." id="VAR_045944" evidence="5">
<original>R</original>
<variation>Q</variation>
<location>
<position position="744"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs770371468." id="VAR_045945" evidence="5">
<original>A</original>
<variation>V</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG6; dbSNP:rs142306293." id="VAR_066987" evidence="6">
<original>G</original>
<variation>D</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs267606697." id="VAR_045946" evidence="5">
<original>G</original>
<variation>D</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs779526640." id="VAR_045947" evidence="5">
<original>G</original>
<variation>S</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3751664." id="VAR_045948" evidence="5">
<original>R</original>
<variation>C</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28365119." id="VAR_045949">
<original>V</original>
<variation>M</variation>
<location>
<position position="812"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs119454949." id="VAR_045950" evidence="5">
<original>V</original>
<variation>M</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs374272094." id="VAR_045951" evidence="5">
<original>G</original>
<variation>S</variation>
<location>
<position position="848"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA6; dbSNP:rs542245543." id="VAR_045952" evidence="5">
<original>D</original>
<variation>N</variation>
<location>
<position position="1463"/>
</location>
</feature>
<feature type="sequence variant" description="In HALD4; changed calcium channel activity; increased aldosterone production in response to potassium ion stimulation; increased expression of genes involved in aldosterone biosynthesis, with the strongest effect observed on CYP11B2 expression in response to potassium ion stimulation." id="VAR_077065" evidence="12">
<original>M</original>
<variation>I</variation>
<location>
<position position="1549"/>
</location>
</feature>
<feature type="sequence variant" description="In HALD4; changed calcium channel activity; dbSNP:rs786205050." id="VAR_077066" evidence="9">
<original>M</original>
<variation>V</variation>
<location>
<position position="1549"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs58124832." id="VAR_061104">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1871"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant responsible for primary aldosteronism found in a patient with aldosterone-producing adenoma; changed Ca(2+) channel activity; dbSNP:rs746967306." id="VAR_077067" evidence="12">
<original>V</original>
<variation>E</variation>
<location>
<position position="1951"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with autism; unknown pathological significance; dbSNP:rs1267377730." id="VAR_078702" evidence="10">
<original>S</original>
<variation>C</variation>
<location>
<position position="1970"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3751886." id="VAR_033698">
<original>E</original>
<variation>G</variation>
<location>
<position position="1974"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1054644." id="VAR_045953" evidence="3 5">
<original>R</original>
<variation>H</variation>
<location>
<position position="2060"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1054645." id="VAR_045954" evidence="5 16 17">
<original>R</original>
<variation>H</variation>
<location>
<position position="2077"/>
</location>
</feature>
<feature type="sequence variant" description="In HALD4; changed calcium channel activity; dbSNP:rs759924732." id="VAR_077068" evidence="12">
<original>P</original>
<variation>L</variation>
<location>
<position position="2083"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200675829." id="VAR_045955" evidence="5">
<original>P</original>
<variation>S</variation>
<location>
<position position="2173"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AC120498." ref="5" evidence="19">
<original>A</original>
<variation>S</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AC120498." ref="5" evidence="19">
<original>E</original>
<variation>K</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AC120498." ref="5" evidence="19">
<original>A</original>
<variation>S</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AC120498." ref="5" evidence="19">
<original>L</original>
<variation>V</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAC42094." ref="6" evidence="19">
<original>S</original>
<variation>T</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAD12646." ref="4" evidence="19">
<original>K</original>
<variation>E</variation>
<location sequence="O95180-2">
<position position="1587"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11157797"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751928"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12891677"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15048902"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15616553"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24277868"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25907736"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26637798"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27149520"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27729216"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864847"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30197081"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9670923"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9930755"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11751928"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15048902"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1395"/>
</source>
</evidence>
<sequence length="2353" mass="259163" checksum="E13E270635173D98" modified="2002-09-19" version="4">MTEGARAADEVRVPLGAPPPGPAALVGASPESPGAPGREAERGSELGVSPSESPAAERGAELGADEEQRVPYPALAATVFFCLGQTTRPRSWCLRLVCNPWFEHVSMLVIMLNCVTLGMFRPCEDVECGSERCNILEAFDAFIFAFFAVEMVIKMVALGLFGQKCYLGDTWNRLDFFIVVAGMMEYSLDGHNVSLSAIRTVRVLRPLRAINRVPSMRILVTLLLDTLPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCFLDSAFVRNNNLTFLRPYYQTEEGEENPFICSSRRDNGMQKCSHIPGRRELRMPCTLGWEAYTQPQAEGVGAARNACINWNQYYNVCRSGDSNPHNGAINFDNIGYAWIAIFQVITLEGWVDIMYYVMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSETKQRESQLMREQRARHLSNDSTLASFSEPGSCYEELLKYVGHIFRKVKRRSLRLYARWQSRWRKKVDPSAVQGQGPGHRQRRAGRHTASVHHLVYHHHHHHHHHYHFSHGSPRRPGPEPGACDTRLVRAGAPPSPPSPGRGPPDAESVHSIYHADCHIEGPQERARVAHAAATAAASLRLATGLGTMNYPTILPSGVGSGKGSTSPGPKGKWAGGPPGTGGHGPLSLNSPDPYEKIPHVVGEHGLGQAPGHLSGLSVPCPLPSPPAGTLTCELKSCPYCTRALEDPEGELSGSESGDSDGRGVYEFTQDVRHGDRWDPTRPPRATDTPGPGPGSPQRRAQQRAAPGEPGWMGRLWVTFSGKLRRIVDSKYFSRGIMMAILVNTLSMGVEYHEQPEELTNALEISNIVFTSMFALEMLLKLLACGPLGYIRNPYNIFDGIIVVISVWEIVGQADGGLSVLRTFRLLRVLKLVRFLPALRRQLVVLVKTMDNVATFCTLLMLFIFIFSILGMHLFGCKFSLKTDTGDTVPDRKNFDSLLWAIVTVFQILTQEDWNVVLYNGMASTSSWAALYFVALMTFGNYVLFNLLVAILVEGFQAEGDANRSDTDEDKTSVHFEEDFHKLRELQTTELKMCSLAVTPNGHLEGRGSLSPPLIMCTAATPMPTPKSSPFLDAAPSLPDSRRGSSSSGDPPLGDQKPPASLRSSPCAPWGPSGAWSSRRSSWSSLGRAPSLKRRGQCGERESLLSGEGKGSTDDEAEDGRAAPGPRATPLRRAESLDPRPLRPAALPPTKCRDRDGQVVALPSDFFLRIDSHREDAAELDDDSEDSCCLRLHKVLEPYKPQWCRSREAWALYLFSPQNRFRVSCQKVITHKMFDHVVLVFIFLNCVTIALERPDIDPGSTERVFLSVSNYIFTAIFVAEMMVKVVALGLLSGEHAYLQSSWNLLDGLLVLVSLVDIVVAMASAGGAKILGVLRVLRLLRTLRPLRVISRAPGLKLVVETLISSLRPIGNIVLICCAFFIIFGILGVQLFKGKFYYCEGPDTRNISTKAQCRAAHYRWVRRKYNFDNLGQALMSLFVLSSKDGWVNIMYDGLDAVGVDQQPVQNHNPWMLLYFISFLLIVSFFVLNMFVGVVVENFHKCRQHQEAEEARRREEKRLRRLERRRRSTFPSPEAQRRPYYADYSPTRRSIHSLCTSHYLDLFITFIICVNVITMSMEHYNQPKSLDEALKYCNYVFTIVFVFEAALKLVAFGFRRFFKDRWNQLDLAIVLLSLMGITLEEIEMSAALPINPTIIRIMRVLRIARVLKLLKMATGMRALLDTVVQALPQVGNLGLLFMLLFFIYAALGVELFGRLECSEDNPCEGLSRHATFSNFGMAFLTLFRVSTGDNWNGIMKDTLRECSREDKHCLSYLPALSPVYFVTFVLVAQFVLVNVVVAVLMKHLEESNKEAREDAELDAEIELEMAQGPGSARRVDADRPPLPQESPGARDAPNLVARKVSVSRMLSLPNDSYMFRPVVPASAPHPRPLQEVEMETYGAGTPLGSVASVHSPPAESCASLQIPLAVSSPARSGEPLHALSPRGTARSPSLSRLLCRQEAVHTDSLEGKIDSPRDTLDPAEPGEKTPVRPVTQGGSLQSPPRSPRPASVRTRKHTFGQRCVSSRPAAPGGEEAEASDPADEEVSHITSSACPWQPTAEPHGPEASPVAGGERDLRRLYSVDAQGFLDKPGRADEQWRPSAELGSGEPGEAKAWGPEAEPALGARRKKKMSPPCISVEPPAEDEGSARPSAAEGGSTTLRRRTPSCEATPHRDSLEPTEGSGAGGDPAAKGERWGQASCRAEHLTVPSFAFEPLDLGVPSGDPFLDGSHSVTPESRASSSGAIVPLEPPESEPPMPVGDPPEKRRGLYLTVPQCPLEKPGSPSATPAPGGGADDPV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

